img

Post-pandemic Era Global Epigenetics Instrument Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 212 | Industry : Medical Devices & Consumables Research Center

Publisher : XMR | Format : PDF

Post-pandemic Era Global Epigenetics Instrument Market Segment Research Report 2024

Summary

The global economy is expected to expand 5.6% in 2021,global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.

The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.

Regional Economic ProspectsGrowth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.

The global Epigenetics Instrument market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to MR Accuracy Reports analysis, The segment in Epigenetics Instrument market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China Epigenetics Instrument production is XX (K Units). US market value in 2021 is about USD XX billion, and US Epigenetics Instrument production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe Epigenetics Instrument production is XX (K Units).

Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Epigenetics Instrument Market by MR Accuracy Reports Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Epigenetics Instrument Market?
Illumina (US)
Thermo Fisher (US)
Diagenode (Belgium)
QIAGEN (Netherlands)
Merck Millipore (US)
Abcam (UK)
Active Motif (US)
New England Biolabs (US)
Agilent (US)
Zymo Research (US)
PerkinElmer (US)
Bio-Rad (US)
Major Type of Epigenetics Instrument Covered in MR Accuracy Reports report
Next-generation Sequencers
qPCR Instruments
Mass Spectrometers
Sonicators
Other
Application Segments Covered in MR Accuracy Reports Market
Oncology
Metabolic Diseases
Developmental Biology
Immunology
Cardiovascular Diseases
Other

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Epigenetics Instrument Market Segment Research Report 2021
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Epigenetics Instrument Market by Value
2.2.1 Global Epigenetics Instrument Revenue by Type
2.2.2 Global Epigenetics Instrument Market by Value (%)
2.3 Global Epigenetics Instrument Market by Production
2.3.1 Global Epigenetics Instrument Production by Type
2.3.2 Global Epigenetics Instrument Market by Production (%)

3. The Major Driver of Epigenetics Instrument Industry
3.1 Historical & Forecast Global Epigenetics Instrument Demand
3.2 Largest Application for Epigenetics Instrument (2017-2027)
3.3 The Major Downstream Company in China Market 2021

4. Global and Regional Epigenetics Instrument Market
4.1 Regional Market Size in Terms of Production & Demand (2021)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Epigenetics Instrument Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Epigenetics Instrument Production, Demand (2017-2027)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe Epigenetics Instrument Production, Demand (2017-2027)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China Epigenetics Instrument Production, Demand (2017-2027)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan Epigenetics Instrument Production, Demand (2017-2027)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India Epigenetics Instrument Production, Demand (2017-2027)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea Epigenetics Instrument Production, Demand (2017-2027)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia Epigenetics Instrument Production, Demand (2017-2027)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global Epigenetics Instrument Average Price Trend
12.1 Market Price for Each Type of Epigenetics Instrument in US (2017-2021)
12.2 Market Price for Each Type of Epigenetics Instrument in Europe (2017-2021)
12.3 Market Price for Each Type of Epigenetics Instrument in China (2017-2021)
12.4 Market Price for Each Type of Epigenetics Instrument in Japan (2017-2021)
12.5 Market Price for Each Type of Epigenetics Instrument in India (2017-2021)
12.6 Market Price for Each Type of Epigenetics Instrument in Korea (2017-2021)
12.7 Market Price for Each Type of Epigenetics Instrument in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
13.1 Epigenetics Instrument Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Epigenetics Instrument

14. Epigenetics Instrument Competitive Landscape
14.1 Illumina (US)
14.1.1 Illumina (US) Company Profiles
14.1.2 Illumina (US) Product Introduction
14.1.3 Illumina (US) Epigenetics Instrument Sales, Revenue (2017-2021)
14.1.4 Strategic initiatives
14.2 Thermo Fisher (US)
14.2.1 Thermo Fisher (US) Company Profiles
14.2.2 Thermo Fisher (US) Product Introduction
14.2.3 Thermo Fisher (US) Epigenetics Instrument Sales, Revenue (2017-2021)
14.2.4 Strategic initiatives
14.3 Diagenode (Belgium)
14.3.1 Diagenode (Belgium) Company Profiles
14.3.2 Diagenode (Belgium) Product Introduction
14.3.3 Diagenode (Belgium) Epigenetics Instrument Sales, Revenue (2017-2021)
14.3.4 Strategic initiatives
14.4 QIAGEN (Netherlands)
14.4.1 QIAGEN (Netherlands) Company Profiles
14.4.2 QIAGEN (Netherlands) Product Introduction
14.4.3 QIAGEN (Netherlands) Epigenetics Instrument Sales, Revenue (2017-2021)
14.4.4 Strategic initiatives
14.5 Merck Millipore (US)
14.5.1 Merck Millipore (US) Company Profiles
14.5.2 Merck Millipore (US) Product Introduction
14.5.3 Merck Millipore (US) Epigenetics Instrument Sales, Revenue (2017-2021)
14.5.4 Strategic initiatives
14.6 Abcam (UK)
14.6.1 Abcam (UK) Company Profiles
14.6.2 Abcam (UK) Product Introduction
14.6.3 Abcam (UK) Epigenetics Instrument Sales, Revenue (2017-2021)
14.6.4 Strategic initiatives
14.7 Active Motif (US)
14.7.1 Active Motif (US) Company Profiles
14.7.2 Active Motif (US) Product Introduction
14.7.3 Active Motif (US) Epigenetics Instrument Sales, Revenue (2017-2021)
14.7.4 Strategic initiatives
14.8 New England Biolabs (US)
14.8.1 New England Biolabs (US) Company Profiles
14.8.2 New England Biolabs (US) Product Introduction
14.8.3 New England Biolabs (US) Epigenetics Instrument Sales, Revenue (2017-2021)
14.8.4 Strategic initiatives
14.9 Agilent (US)
14.9.1 Agilent (US) Company Profiles
14.9.2 Agilent (US) Product Introduction
14.9.3 Agilent (US) Epigenetics Instrument Sales, Revenue (2017-2021)
14.9.4 Strategic initiatives
14.10 Zymo Research (US)
14.10.1 Zymo Research (US) Company Profiles
14.10.2 Zymo Research (US) Product Introduction
14.10.3 Zymo Research (US) Epigenetics Instrument Sales, Revenue (2017-2021)
14.10.4 Strategic initiatives
14.11 PerkinElmer (US)
14.12 Bio-Rad (US)
15. Conclusion


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Epigenetics Instrument Industry (Volume)
Figure 2. Epigenetics Instrument Production & Demand by Regions in 2021
Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
Figure 4. The Top 10 and 5 Players Market Share by Epigenetics Instrument Revenue in 2021
Figure 5. US Epigenetics Instrument Production, Demand (2017-2027)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Epigenetics Instrument Production, Demand (2017-2027)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Epigenetics Instrument Production, Demand (2017-2027)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Epigenetics Instrument Production, Demand (2017-2027)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Epigenetics Instrument Production, Demand (2017-2027)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Epigenetics Instrument Production, Demand (2017-2027)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Epigenetics Instrument Production, Demand (2017-2027)
Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Epigenetics Instrument Revenue, by Type (Million USD) (2017-2027)
Table 4. Epigenetics Instrument Production, by Type (K Unit) (2017-2027)
Table 5. Epigenetics Instrument Demand (K Unit) by Application (2017-2027)
Table 6. Epigenetics Instrument Demand (Million USD) by Application (2017-2027)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2021)
Table 9. Regional Market Share in Terms of Revenue (2021&2027)
Table 10. Ranking of Global Top Epigenetics Instrument Companies by Revenue, Concentration Ratio in 2021
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Epigenetics Instrument Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Epigenetics Instrument Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Epigenetics Instrument Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Epigenetics Instrument Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Epigenetics Instrument Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Epigenetics Instrument Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Epigenetics Instrument Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Epigenetics Instrument in US (2017-2021)
Table 53. Market Price (USD/Unit) for Each Type of Epigenetics Instrument in Europe (2017-2021)
Table 54. Market Price (USD/Unit) for Each Type of Epigenetics Instrument in China (2017-2021)
Table 55. Market Price (USD/Unit) for Each Type of Epigenetics Instrument in Japan (2017-2021)
Table 56. Market Price (USD/Unit) for Each Type of Epigenetics Instrument in India (2017-2021)
Table 57. Market Price (USD/Unit) for Each Type of Epigenetics Instrument in Korea (2017-2021)
Table 58. Market Price (USD/Unit) for Each Type of Epigenetics Instrument in Southeast Asia (2017-2021)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Illumina (US) Profiles
Table 61. Illumina (US) Epigenetics Instrument Product Introduction
Table 62. Illumina (US) Epigenetics Instrument Sales (Unit), Revenue (Million USD) (2017-2021)
Table 63. Illumina (US) Strategic initiatives
Table 64. Thermo Fisher (US) Profiles
Table 65. Thermo Fisher (US) Epigenetics Instrument Product Introduction
Table 66. Thermo Fisher (US) Epigenetics Instrument Sales (Unit), Revenue (Million USD) (2017-2021)
Table 67. Thermo Fisher (US) Strategic initiatives
Table 68. Diagenode (Belgium) Profiles
Table 69. Diagenode (Belgium) Epigenetics Instrument Product Introduction
Table 70. Diagenode (Belgium) Epigenetics Instrument Sales (Unit), Revenue (Million USD) (2017-2021)
Table 71. Diagenode (Belgium) Strategic initiatives
Table 72. QIAGEN (Netherlands) Profiles
Table 73. QIAGEN (Netherlands) Epigenetics Instrument Product Introduction
Table 74. QIAGEN (Netherlands) Epigenetics Instrument Sales (Unit), Revenue (Million USD) (2017-2021)
Table 75. QIAGEN (Netherlands) Strategic initiatives
Table 76. Merck Millipore (US) Profiles
Table 77. Merck Millipore (US) Epigenetics Instrument Product Introduction
Table 78. Merck Millipore (US) Epigenetics Instrument Sales (Unit), Revenue (Million USD) (2017-2021)
Table 79. Merck Millipore (US) Strategic initiatives
Table 80. Abcam (UK) Profiles
Table 81. Abcam (UK) Epigenetics Instrument Product Introduction
Table 82. Abcam (UK) Epigenetics Instrument Sales (Unit), Revenue (Million USD) (2017-2021)
Table 83. Abcam (UK) Strategic initiatives
Table 84. Active Motif (US) Profiles
Table 85. Active Motif (US) Epigenetics Instrument Product Introduction
Table 86. Active Motif (US) Epigenetics Instrument Sales (Unit), Revenue (Million USD) (2017-2021)
Table 87. Active Motif (US) Strategic initiatives
Table 88. New England Biolabs (US) Profiles
Table 89. New England Biolabs (US) Epigenetics Instrument Product Introduction
Table 90. New England Biolabs (US) Epigenetics Instrument Sales (Unit), Revenue (Million USD) (2017-2021)
Table 91. New England Biolabs (US) Strategic initiatives
Table 92. Agilent (US) Profiles
Table 93. Agilent (US) Epigenetics Instrument Product Introduction
Table 94. Agilent (US) Epigenetics Instrument Sales (Unit), Revenue (Million USD) (2017-2021)
Table 95. Agilent (US) Strategic initiatives
Table 97. Zymo Research (US) Profiles
Table 98. Zymo Research (US) Epigenetics Instrument Product Introduction
Table 99. Zymo Research (US) Epigenetics Instrument Sales (Unit), Revenue (Million USD) (2017-2021)
Table 100. Zymo Research (US) Strategic initiatives
Table 101. PerkinElmer (US) Profiles
Table 102. PerkinElmer (US) Epigenetics Instrument Product Introduction
Table 103. PerkinElmer (US) Epigenetics Instrument Sales (Unit), Revenue (Million USD) (2017-2021)
Table 104. PerkinElmer (US) Strategic initiatives
Table 105. Bio-Rad (US) Profiles
Table 106. Bio-Rad (US) Epigenetics Instrument Product Introduction
Table 107. Bio-Rad (US) Epigenetics Instrument Sales (Unit), Revenue (Million USD) (2017-2021)